Results 191 to 200 of about 1,142,441 (317)
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Dispersion engineering by rotational symmetry breaking in an optical microcavity. [PDF]
Ren JZ +5 more
europepmc +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
A Novel Technique for Quality Control of Microinjection Molding. [PDF]
Daoud AN +3 more
europepmc +1 more source
Engineering Control of Occupational Diseases [PDF]
openaire +2 more sources
Editorial: Evolution mechanism and control method of engineering disasters under complex environment [PDF]
Jianyong Han +5 more
openalex +1 more source
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
Correction: A hybrid approach for regionalization of precipitation based on maximal discrete wavelet transform and growing neural gas network clustering. [PDF]
Tao X, Ben M, Xuan HCY, Arshaghi A.
europepmc +1 more source

